In vivo affinity maturation of the CD4 domains of an HIV-1-entry inhibitor
{{output}}
Human proteins repurposed as biologics for clinical use have been engineered through in vitro techniques that improve the affinity of the biologics for their ligands. However, the techniques do not select against properties, such as protease sensitivity or sel... ...
